Global Metamizole API Market Growth 2026-2032
Description
The global Metamizole API market size is predicted to grow from US$ 170 million in 2025 to US$ 155 million in 2032; it is expected to grow at a CAGR of -1.5% from 2026 to 2032.
Metamizole API (Analgin API) is a pure compound that can be formulated into various dosage forms, such as injections (IV/IM), oral tablets, syrups, or rectal suppositories. It is primarily used in medical settings requiring rapid relief of severe pain or fever. Metamizole is a non-opioid analgesic and antipyretic used to treat severe pain and fever. In 2025, global Metamizole API production reached approximately 19.31 K MT. Global production capacity in 2025 is approximately 26 K MT. The Metamizole API industrial chain is upstreamed by basic petrochemicals and inorganic reagents (e.g., aromatic feedstocks/solvents, nitrite systems, bisulfite-related reagents, and C1 chemicals like formaldehyde/methanol). Downstream, formulators manufacture tablets and injections for hospital and retail markets in countries where metamizole remains approved.
The metamizole API market is expected to maintain a certain level of demand in the coming years, supported by continued clinical demand in regions where it is not explicitly prohibited (such as Latin America, parts of Europe, and parts of Asia).
LP Information, Inc. (LPI) ' newest research report, the “Metamizole API Industry Forecast” looks at past sales and reviews total world Metamizole API sales in 2025, providing a comprehensive analysis by region and market sector of projected Metamizole API sales for 2026 through 2032. With Metamizole API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metamizole API industry.
This Insight Report provides a comprehensive analysis of the global Metamizole API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Metamizole API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Metamizole API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metamizole API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metamizole API.
This report presents a comprehensive overview, market shares, and growth opportunities of Metamizole API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
99% and Above
Below 99%
Segmentation by Finished Dosage Form:
Analgin Tablets
Analgin Oral Solution
Analgin Injection
Others
Segmentation by Synthesis Route:
Traditional Multi-step Chemical Synthesis
Process-optimized Synthesis Routes
High-yield and Impurity-controlled Processes
Segmentation by Impurity & Safety Risk:
Standard Impurity Control Grade
Low-risk Impurity Grade
High-safety Grade
Segmentation by Application:
Human Use
Veterinary Use
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Xinhua Pharmaceutical Company Limited
Moehs Group
Wuyao Pharmaceutical Co., Ltd
Jiheng Pharmaceutical Co., Ltd
Haisen Pharma
Hachidai Pharmaceutical Co Ltd
Vani Pharma Labs Limited
Huadong Medicine (Xi’an) Bohua Pharmaceutical Co., Ltd.
Chemcopia Ingredients Pvt Ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global Metamizole API market?
What factors are driving Metamizole API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Metamizole API market opportunities vary by end market size?
How does Metamizole API break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Metamizole API (Analgin API) is a pure compound that can be formulated into various dosage forms, such as injections (IV/IM), oral tablets, syrups, or rectal suppositories. It is primarily used in medical settings requiring rapid relief of severe pain or fever. Metamizole is a non-opioid analgesic and antipyretic used to treat severe pain and fever. In 2025, global Metamizole API production reached approximately 19.31 K MT. Global production capacity in 2025 is approximately 26 K MT. The Metamizole API industrial chain is upstreamed by basic petrochemicals and inorganic reagents (e.g., aromatic feedstocks/solvents, nitrite systems, bisulfite-related reagents, and C1 chemicals like formaldehyde/methanol). Downstream, formulators manufacture tablets and injections for hospital and retail markets in countries where metamizole remains approved.
The metamizole API market is expected to maintain a certain level of demand in the coming years, supported by continued clinical demand in regions where it is not explicitly prohibited (such as Latin America, parts of Europe, and parts of Asia).
LP Information, Inc. (LPI) ' newest research report, the “Metamizole API Industry Forecast” looks at past sales and reviews total world Metamizole API sales in 2025, providing a comprehensive analysis by region and market sector of projected Metamizole API sales for 2026 through 2032. With Metamizole API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metamizole API industry.
This Insight Report provides a comprehensive analysis of the global Metamizole API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Metamizole API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Metamizole API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metamizole API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metamizole API.
This report presents a comprehensive overview, market shares, and growth opportunities of Metamizole API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
99% and Above
Below 99%
Segmentation by Finished Dosage Form:
Analgin Tablets
Analgin Oral Solution
Analgin Injection
Others
Segmentation by Synthesis Route:
Traditional Multi-step Chemical Synthesis
Process-optimized Synthesis Routes
High-yield and Impurity-controlled Processes
Segmentation by Impurity & Safety Risk:
Standard Impurity Control Grade
Low-risk Impurity Grade
High-safety Grade
Segmentation by Application:
Human Use
Veterinary Use
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Xinhua Pharmaceutical Company Limited
Moehs Group
Wuyao Pharmaceutical Co., Ltd
Jiheng Pharmaceutical Co., Ltd
Haisen Pharma
Hachidai Pharmaceutical Co Ltd
Vani Pharma Labs Limited
Huadong Medicine (Xi’an) Bohua Pharmaceutical Co., Ltd.
Chemcopia Ingredients Pvt Ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global Metamizole API market?
What factors are driving Metamizole API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Metamizole API market opportunities vary by end market size?
How does Metamizole API break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
86 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Metamizole API by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Metamizole API by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
